Sigma Planning Corp cut its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 46.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,128 shares of the financial services provider’s stock after selling 2,707 shares during the period. Sigma Planning Corp’s holdings in iShares Biotechnology ETF were worth $425,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Glass Jacobson Investment Advisors llc grew its stake in shares of iShares Biotechnology ETF by 150.6% in the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after buying an additional 122 shares in the last quarter. Values First Advisors Inc. bought a new position in shares of iShares Biotechnology ETF in the fourth quarter valued at $43,000. Horizon Bancorp Inc. IN bought a new position in shares of iShares Biotechnology ETF in the third quarter valued at $44,000. Tennessee Valley Asset Management Partners bought a new position in shares of iShares Biotechnology ETF in the fourth quarter valued at $44,000. Finally, Column Capital Advisors LLC bought a new position in shares of iShares Biotechnology ETF in the third quarter valued at $49,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.
iShares Biotechnology ETF Price Performance
NASDAQ:IBB opened at $126.49 on Friday. The firm has a fifty day simple moving average of $134.45 and a 200 day simple moving average of $129.71. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $141.16.
iShares Biotechnology ETF Announces Dividend
iShares Biotechnology ETF Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Featured Articles
- Five stocks we like better than iShares Biotechnology ETF
- Where to Find Earnings Call Transcripts
- 3 Stocks Leading the U.S. Agriculture Comeback
- 3 Ways To Invest In Coffee, Other Than Drinking It
- How to Use Put Debit Spreads to Profit From Falling Stocks
- What is the NASDAQ Stock Exchange?
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.